Status:
UNKNOWN
Long-Term Treatment of Collagenous Colitis With Budesonide
Lead Sponsor:
Bonderup, Ole K., M.D.
Collaborating Sponsors:
AstraZeneca
Conditions:
Collagenous Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with p...
Eligibility Criteria
Inclusion
- Histological criteria of Collagenous colitis
- Clinical activity (\> 3 stools/day)
Exclusion
- Treatment of Collagenous colitis within the last 3 months
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00139165
Start Date
September 1 2004
End Date
March 1 2006
Last Update
March 6 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of medical gastroenterology
Aalborg, Denmark, 9100
2
Dept. of medical gastroenterology
Aarhus, Denmark, 8000